Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
419.23
+1.91 (+0.46%)
Streaming Delayed Price
Updated: 1:25 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
380,327
Open
419.48
Bid (Size)
419.03 (1)
Ask (Size)
419.42 (4)
Prev. Close
417.32
Today's Range
415.06 - 420.67
52wk Range
309.43 - 448.40
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why
Today 12:58 EDT
The company is working to launch its Vertex-partnered gene-editing drug for sickle cell disease and beta thalassemia.
Via
Investor's Business Daily
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
March 26, 2024
These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run.
Via
InvestorPlace
Performance
YTD
+2.02%
+2.02%
1 Month
-3.29%
-3.29%
3 Month
+2.74%
+2.74%
6 Month
+19.90%
+19.90%
1 Year
+33.83%
+33.83%
More News
Read More
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,400 Today
March 25, 2024
Via
Benzinga
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
March 25, 2024
Via
InvestorPlace
FDA Approves Vertex Pharmaceuticals (NASDAQ:VRTX) VX-407 for Phase I Study in Groundbreaking Move Against Polycystic Kidney Disease”
March 25, 2024
Via
AB Newswire
Exposures
Product Safety
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,500 Today
February 27, 2024
Via
Benzinga
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
March 21, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
3 Biopharma Stocks Predicted to Soar in Q2 2024
March 20, 2024
Via
InvestorPlace
Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
March 20, 2024
Via
MarketBeat
Exposures
Product Safety
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
March 19, 2024
Via
InvestorPlace
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
March 17, 2024
Via
The Motley Fool
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
March 17, 2024
Via
The Motley Fool
Forget Tesla, Buy This Magnificent Healthcare Stock Instead
March 17, 2024
Via
The Motley Fool
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
March 09, 2024
Via
The Motley Fool
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years
March 08, 2024
Via
Benzinga
The Top 3 Biotech Stocks to Buy in March 2024
March 06, 2024
Via
InvestorPlace
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market
March 05, 2024
Via
The Motley Fool
Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making
March 05, 2024
Via
InvestorPlace
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
March 04, 2024
Via
InvestorPlace
ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential
March 04, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
March 02, 2024
Via
The Motley Fool
3 Magnificent Growth Stocks to Buy in March
March 02, 2024
Via
The Motley Fool
Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List
March 01, 2024
Via
Benzinga
These 4 Stocks Are the "Magnificent Seven" of Healthcare
March 01, 2024
Via
The Motley Fool
Could These 3 Companies Headline a "Magnificent Seven" of Biotech Stocks?
February 29, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.